Landec Corporation to Showcase Lifecore Biomedical at the 2022 ICR Conference on Monday, January 10, 2022
The Company will provide an updated Lifecore focused presentation on Landec’s investor relations website and discuss the business’s growth strategy that has generated compound annual revenue growth of more than 15% since 2010, its unique position within the injectables and CDMO marketplace, and its development pipeline that will support continued long-term growth in the years ahead.
The Company will present on
About
Investor Relations
(646) 277-1263
jeff.sonnek@icrinc.com

Source: Landec Corporation